Fonte: Atherosclerosis. Nome do evento: Brazilian Congress of Atherosclerosis-Brazilian Society of Cardiology. Unidade: FCFRP
Assuntos: DOENÇAS CARDIOVASCULARES, FÁRMACOS, DISLIPIDEMIAS (TRATAMENTO)
ABNT
CARDOSO, A. P. Z. et al. Analysis of the cardiovascular morbimortality in patients with dyslipidemia en treatment with lipid-lowering drugs in Ribeirão preto, SP. Atherosclerosis. Shannon: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2009APA
Cardoso, A. P. Z., Rocha, A. F. P., Vieira, C. P., Viana, M. A. S., Oliveira, R. M. A., Ribeiro, R. M. P., et al. (2009). Analysis of the cardiovascular morbimortality in patients with dyslipidemia en treatment with lipid-lowering drugs in Ribeirão preto, SP. Atherosclerosis. Shannon: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.NLM
Cardoso APZ, Rocha AFP, Vieira CP, Viana MAS, Oliveira RMA, Ribeiro RMP, Araújo MCS, Valdevite LM, Uyemura SA, Cesarino EJ. Analysis of the cardiovascular morbimortality in patients with dyslipidemia en treatment with lipid-lowering drugs in Ribeirão preto, SP. Atherosclerosis. 2009 ; 10( 3): 33.[citado 2024 out. 31 ]Vancouver
Cardoso APZ, Rocha AFP, Vieira CP, Viana MAS, Oliveira RMA, Ribeiro RMP, Araújo MCS, Valdevite LM, Uyemura SA, Cesarino EJ. Analysis of the cardiovascular morbimortality in patients with dyslipidemia en treatment with lipid-lowering drugs in Ribeirão preto, SP. Atherosclerosis. 2009 ; 10( 3): 33.[citado 2024 out. 31 ]